The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProteome Share News (PRM)

Share Price Information for Proteome (PRM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.51
Bid: 3.02
Ask: 4.00
Change: 0.00 (0.00%)
Spread: 0.98 (32.45%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.51
PRM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Thoma Bravo snaps up Darktrace for USD5 billion

Fri, 26th Apr 2024 09:14

(Alliance News) - Stock prices in London opened higher on Friday, as investors shook off nerves ahead of US inflation data this afternoon.

The FTSE 100 index opened up 42.14 points, 0.5%, at 8,121.00. The FTSE 250 was up 151.94 points, 0.8%, at 19,753.92, and the AIM All-Share was up 2.41 points, 0.3%, at 755.53.

The Cboe UK 100 was up 0.6% at 811.01, the Cboe UK 250 was up 0.7% at 17064.32, and the Cboe Small Companies was flat at 15,446.19.

In European equities on Friday, the CAC 40 in Paris was up 0.3%, while the DAX 40 in Frankfurt was up 0.5%.

Friday's economic calendar has the monthly US PCE reading for March at 1330 BST.

The annual rise in the core PCE index, the Fed's preferred gauge, is expected to have eased to 2.6% in March from 2.8% in February.

"The fear is to see a higher inflation print, of course, which would further batter the Fed cut expectations," said Ipek Ozkardeskaya at Swissquote Bank.

Data on Thursday showed that US economic growth slowed in the first three months of the year, coming in weaker than expected, though inflation pressure picked up.

The BEA said US gross domestic product grew 1.6% quarter-on-quarter on an annualised basis in the three months to March 31. Growth eased from a 3.4% rally in the final three months of 2023.

The latest reading fell short of FXStreet cited consensus, which had predicted a 2.5% climb.

In the US on Thursday, Wall Street ended lower, with the Dow Jones Industrial Average down 1.0%, the S&P 500 down 0.5% and the Nasdaq Composite down 0.6%.

The pound was quoted at USD1.2507 early on Friday in London, up compared to USD1.2490 at the equities close on Thursday. The euro stood at USD1.0730, up against USD1.0713.

In Japan on Friday, the Nikkei 225 index in Tokyo was up 0.8%.

The Bank of Japan kept its ultra-low interest rates unchanged Friday and stopped short of signalling another hike, pushing the yen to a fresh 34-year low against the dollar.

Officials last month announced the first increase in borrowing costs for 17 years as inflation continued to stick above their two percent target but warned they would take a steady approach to normalising monetary policy.

While widely expected, Friday's decision had been keenly awaited to see if decision-makers would respond to a drop in the yen that has pushed it to levels not seen since 1990.

Against the yen, the dollar was trading at JPY156.70, higher compared to JPY155.52.

In the FTSE 100, Anglo American lost 1.0%, after it said its board has "unanimously" rejected an "opportunistic" offer from larger peer BHP.

This comes after Australia's BHP on Thursday confirmed it had offered to buy Anglo American in an all-share deal valuing the mining group at GBP31.1 billion.

In a formal response, Anglo American on Friday said its board had considered the BHP proposal with its advisers and concluded that the offer "significantly undervalues" the company and its future prospects.

"In addition, the proposal contemplates a structure which the board believes is highly unattractive for Anglo American's shareholders, given the uncertainty and complexity inherent in the proposal, and significant execution risks," Anglo American said.

NatWest rose 3.2%.

The Edinburgh-based bank reported that total income fell to GBP3.48 billion in the first quarter of 2024 from GBP3.88 billion a year earlier. Pretax profit fell to GBP1.33 billion from GBP1.81 billion.

Chief Executive Paul Thwaite said: "Our performance is grounded in the vital role we play in the economy and in the lives of our 19 million customers. Though macro-uncertainty continues, customer confidence and activity is improving, with both lending and deposits up in the quarter and impairments remaining low, reflecting our well-diversified business."

In the FTSE 250, Darktrace shot up 20% at 619.20p, after it agreed to be taken over by Thoma Bravo.

Darktrace said it has agreed to an all-cash takeover offer worth USD5.32 billion from funds managed by private equity firm Thoma Bravo.

Chicago-based Thoma Bravo, which focuses on software investments, offers USD7.75 in cash per Darktrace share. This is equivalent to 620 pence, a 20% premium to Darktrace's close in London on Thursday.

Darktrace directors will unanimously recommend the offer to shareholders, and Thoma Bravo already has commitments to accepts from shareholders representing 14.4% of the company.

On AIM, Proteome Sciences jumped 20%.

Proteome said it has secured a contract win from an unnamed US biopharmaceutical company, using the its mass spectrometry services for the analysis of samples for an on-going clinical trial.

The contract is valued at over GBP500,000.

In China, the Shanghai Composite was up 1.2%, while the Hang Seng index in Hong Kong was up 2.2%. The S&P/ASX 200 in Sydney closed down 1.4%

Brent oil was quoted at USD88.12 a barrel early in London on Friday, up from USD86.48 late Thursday.

Gold was quoted at USD2,345.60 an ounce, higher against USD2,331.32.

By Sophie Rose, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
26 Apr 2024 11:18

Proteome wins GBP500,000 deal to supply mass spectrometry services

(Alliance News) - Proteome Sciences PLC on Friday said it won a contract from an unnamed US biopharmaceutical company to use Proteome's mass spectrometry services.

Read more
26 Apr 2024 10:40

AIM WINNERS & LOSERS: Proteome Sciences rises on GBP500,000 contract

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
26 Apr 2024 09:45

Proteome Sciences secures contract win with US biopharmaceutical firm

(Sharecast News) - Contract proteomics service Proteome Sciences has secured a contract win from a US biopharmaceutical company using the company's mass spectrometry services for the analysis of samples for an on-going clinical trial.

Read more
10 Apr 2024 11:26

Proteome Sciences shares drop as revenue plunges and swings to loss

(Alliance News) - Proteome Sciences PLC on Wednesday said it swung to a loss in 2023 on higher costs, and saw its revenue plunge on contract delays.

Read more
2 Jan 2024 14:44

Proteome launches San Diego lab operations

(Sharecast News) - Proteomics services provider Proteome Sciences announced the installation and start of operations at its new laboratory in San Diego, California, on Tuesday.

Read more
2 Jan 2024 10:52

IN BRIEF: Proteome Sciences says San Diego lab now fully operational

Proteome Sciences PLC - London-based protein-focused drug development services provider - Completes installation and setup of equipment in its new lab in San Diego, California. The lab is now fully operational. Back in May, Proteome had announced it was expanding its proteomics services to the US. Says that the lab is "well placed to serve demand from a growing number of US customers looking to outsource proteomics projects to underpin their drug development programmes".

Read more
1 Dec 2023 12:01

Proteome Sciences issues profit warning after project delays

(Sharecast News) - Proteome Sciences, the AIM-listed protein sequencing contract research organisation, has warned it will swing to a net loss this year with full-year sales lower than expected.

Read more
30 Nov 2023 11:04

AIM WINNERS & LOSERS: Totally slides again; Proteome warns on earnings

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
30 Nov 2023 09:42

Proteome Sciences shares drop as cuts annual revenue outlook

(Alliance News) - Proteome Sciences PLC shares plummeted on Thursday, after it cut its revenue outlook for 2023 amid delays to projects.

Read more
2 Oct 2023 10:17

Proteome Sciences sees shares surge on SysQuant service launch

(Alliance News) - Proteome Sciences PLC on Monday launched SysQuant SCP, a commercial service for single cell proteomics using isobaric labelling reagents.

Read more
25 Aug 2023 12:07

LONDON MARKET MIDDAY: FTSE 100 pushes higher ahead of Fed chair speech

(Alliance News) - The FTSE 100 edged higher at midday on Friday as all eyes turned to US Federal Reserve Chair Jerome Powell's address at Jackson Hole later in the day.

Read more
25 Aug 2023 10:26

AIM WINNERS & LOSERS: Panthera Resources secures litigation financing

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
25 Aug 2023 09:11

Proteome Sciences revenue, earnings dip in firist half

(Sharecast News) - Proteome Sciences released its unaudited financial results for the first six months of the year on Friday, reporting an increase in its proteomics services revenues to £1.01m, from £0.85m a year earlier.

Read more
25 Aug 2023 09:10

Proteome Sciences shares fall as swings to interim loss on costs

(Alliance News) - Proteome Sciences PLC on Friday reported higher costs in the first half of 2023 despite revenue remaining virtually flat, causing a swing to a loss.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.